A business incubator on Ohio University’s campus is opening section that will include biotechnology support and other components.The Ohio University Innovation Center‘s new biotech research and development facility will feature “state-of-the-art instrumentation and research equipment for chemical and biomedical analysis,” according to the university.The new biotech expansion is intended for use by OU faculty, staff [...]

An Ohio startup is developing a new antibacterial drug that would keep so-called “superbugs” such as MRSA from replicating in the body.Promiliad Biopharma is hoping its early development efforts yield a new drug capable of beating bacteria that have grown resistant to most antibiotics on the market today. The most well-known example is a Methicillin-resistant [...]

An Ohio University startup is developing a medical device it hopes will represent a breakthrough in treating patients suffering from tinnitus, a ringing or buzzing in the ears.Sanuthera’s device involves wireless ear buds connected to an MP3 player that can be customized to a patient’s preference to play a number of sounds aimed at masking [...]

Ohio University‘s medical school will use a $105 million gift to establish a new campus in Central Ohio with an eye toward boosting the number of primary care doctors in the state.The gift, which university officials described as the largest ever for an Ohio institution of higher learning, comes from the Osteopathic Heritage Foundations, a [...]

The deal with Phosplatin Therapeutics could lead to the development of a new ovarian cancer therapeutic, and more royalty income for Ohio University.

Ohio State University officials are talking up an idea for a $100 million venture capital fund that’d be structured as a partnership between the state’s public universities and private industry.

While there’s plenty of optimism surrounding Interthyr, it’ll be awhile before university officials know what kind of potential they’re sitting on. No human testing of the company’s drug candidate for cancer and autoimmune disorders has occurred yet, and it’s unlikely to happen until 2012.

Ohio University received $8.2 million in fiscal 2010 from licensing technologies that were discovered by its researchers, an increase of 19 percent from last year.The vast majority of that revenue–about $8 million–came from fromPfizer Corp. from a license for a growth hormone antagonist that became the basis for the drug Somavert, according to a statement [...]

San Diego diagnostic test maker Quidel Corp. has closed its acquisition of Diagnostic Hybrids Inc. for about $130 million in cash. Announced in mid-January, the acquisition is expected to add depth and innovation to Quidel’s line of rapid, point-of-care tests for pregnancy, infectious diseases, cancer, bone health and autoimmune disorders.

Gov. Ted Strickland and Ohio Board of Regents Chancellor Eric Fingerhut donned their high-tech marketing hats Friday, touting the state’s leadership in biomedical and health care innovation by announcing centers of excellence at 14 universities.